Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
Ville‐Petteri Mäkinen(Helsinki University Hospital), Johan Wadén(Helsinki University Hospital), Milla Rosengård‐Bärlund, Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Markku Saraheimo(Helsinki University Hospital), Daniel Gordin(Helsinki University Hospital), Maija Parkkonen(University of Helsinki), Lena M. Thorn(University of Helsinki), Kimmo Kaski(Aalto University), Outi Heikkilä(Helsinki University Hospital), Mika Ala‐Korpela(University of Oulu), Janne Kytö(Helsinki University Hospital), Laura Kyllönen(Helsinki University Hospital), Nina Tolonen(University of Helsinki), Kustaa Hietala(Helsinki University Hospital)
Cited by 92
Related Papers
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428